A mathematical model of hiPSC cardiomyocytes electromechanics.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
11 2021
Historique:
revised: 18 10 2021
received: 05 08 2021
accepted: 02 11 2021
entrez: 26 11 2021
pubmed: 27 11 2021
medline: 17 3 2022
Statut: ppublish

Résumé

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are becoming instrumental in cardiac research, human-based cell level cardiotoxicity tests, and developing patient-specific care. As one of the principal functional readouts is contractility, we propose a novel electromechanical hiPSC-CM computational model named the hiPSC-CM-CE. This model comprises a reparametrized version of contractile element (CE) by Rice et al., 2008, with a new passive force formulation, integrated into a hiPSC-CM electrophysiology formalism by Paci et al. in 2020. Our simulated results were validated against in vitro data reported for hiPSC-CMs at matching conditions from different labs. Specifically, key action potential (AP) and calcium transient (CaT) biomarkers simulated by the hiPSC-CM-CE model were within the experimental ranges. On the mechanical side, simulated cell shortening, contraction-relaxation kinetic indices (RT

Identifiants

pubmed: 34825519
doi: 10.14814/phy2.15124
pmc: PMC8617339
doi:

Substances chimiques

Calcium Channel Agonists 0
Calcium Channel Blockers 0
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester 71145-03-4
Verapamil CJ0O37KU29

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15124

Informations de copyright

© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Références

Prog Biophys Mol Biol. 2016 Jan;120(1-3):270-80
pubmed: 26724571
Br J Pharmacol. 1989 Feb;96(2):333-40
pubmed: 2466518
Clin Pharmacol Ther. 2019 Feb;105(2):466-475
pubmed: 30151907
J Mol Cell Cardiol. 2017 May;106:68-83
pubmed: 28392437
PLoS Comput Biol. 2011 May;7(5):e1002061
pubmed: 21637795
J Physiol. 2017 Oct 1;595(19):6313-6326
pubmed: 28771742
J Mol Cell Cardiol. 2011 Jan;50(1):165-74
pubmed: 21035455
Sci Rep. 2014 May 02;4:4871
pubmed: 24786000
PLoS Comput Biol. 2015 Aug 11;11(8):e1004376
pubmed: 26262582
Front Pharmacol. 2021 Mar 15;12:604713
pubmed: 33841140
J Cardiovasc Pharmacol. 2011 Jan;57(1):79-85
pubmed: 20980921
JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740
pubmed: 30623132
J Mol Cell Cardiol. 2015 Apr;81:162-75
pubmed: 25724724
J Cardiovasc Pharmacol. 2020 Dec 15;77(3):300-316
pubmed: 33323698
Front Physiol. 2017 Dec 19;8:1073
pubmed: 29311989
Biophys J. 2020 May 19;118(10):2596-2611
pubmed: 32298635
Circ Res. 1999 Mar 5;84(4):475-83
pubmed: 10066683
J Physiol. 2019 Sep;597(17):4533-4564
pubmed: 31278749
Front Physiol. 2011 Aug 11;2:43
pubmed: 21886622
Front Physiol. 2018 Jun 26;9:709
pubmed: 29997516
Interface Focus. 2013 Apr 6;3(2):20120076
pubmed: 24427525
Prog Biophys Mol Biol. 2021 Jan;159:58-74
pubmed: 32710902
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H91-9
pubmed: 15001446
Biophys J. 2010 May 19;98(10):2254-64
pubmed: 20483334
J Mol Cell Cardiol. 2008 Aug;45(2):300-12
pubmed: 18550079
Cardiovasc Res. 2020 Feb 1;116(2):368-382
pubmed: 31049579
Biomech Model Mechanobiol. 2018 Feb;17(1):205-221
pubmed: 28861632
Ann Biomed Eng. 2018 Jan;46(1):148-158
pubmed: 28975460
J Cardiovasc Electrophysiol. 1994 Nov;5(11):933-44
pubmed: 7889233
Ther Innov Regul Sci. 2019 Jul;53(4):519-525
pubmed: 30157676
Biomech Model Mechanobiol. 2014 Jun;13(3):585-97
pubmed: 23942910
J Biomech Eng. 2014 May;136(5):051005
pubmed: 24615475
J Physiol. 1992 Aug;454:619-42
pubmed: 1474506
J Cardiovasc Electrophysiol. 2010 Apr;21(4):441-7
pubmed: 19909385
Biophys J. 2006 Mar 1;90(5):1697-722
pubmed: 16339881
J Mol Cell Cardiol. 2014 Dec;77:178-91
pubmed: 25257913
Front Physiol. 2020 Apr 15;11:314
pubmed: 32351400
Elife. 2019 Dec 24;8:
pubmed: 31868580
Biomech Model Mechanobiol. 2019 Jun;18(3):813-828
pubmed: 30617526
Curr Drug Deliv. 2021 Mar 16;:
pubmed: 33726647
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):418-428
pubmed: 28648627
J Mol Cell Cardiol. 2010 Jan;48(1):112-21
pubmed: 19835882
Int J Pharm. 2019 Mar 25;559:113-129
pubmed: 30654060
PLoS Comput Biol. 2009 Apr;5(4):e1000371
pubmed: 19390615
J Physiol. 2012 Sep 15;590(18):4553-69
pubmed: 22615436
Pflugers Arch. 1993 Aug;424(3-4):343-53
pubmed: 7692395
Am J Physiol. 1990 Jun;258(6 Pt 2):H1796-805
pubmed: 2163219
Nat Commun. 2019 May 15;10(1):2168
pubmed: 31092830
Int J Mol Sci. 2018 Nov 13;19(11):
pubmed: 30428582
Philos Trans A Math Phys Eng Sci. 2008 Sep 28;366(1879):3361-80
pubmed: 18593662
J Physiol. 2002 Nov 1;544(3):817-30
pubmed: 12411526
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1453-H1462
pubmed: 30141984
Ann Biomed Eng. 2013 Nov;41(11):2334-48
pubmed: 23722932
Front Physiol. 2017 Sep 12;8:668
pubmed: 28955244
Front Physiol. 2018 Feb 07;9:80
pubmed: 29467678
Br J Pharmacol. 2011 Jun;163(4):675-93
pubmed: 21306581
Biophys J. 2008 Sep;95(5):2368-90
pubmed: 18234826
Circulation. 2016 Nov 15;134(20):1557-1567
pubmed: 27737958
Tissue Eng Part A. 2018 Feb;24(3-4):287-300
pubmed: 28498040
Heart Rhythm. 2007 May;4(5):638-47
pubmed: 17467634
Langmuir. 2021 Feb 2;37(4):1551-1562
pubmed: 33465311
Circ Res. 1991 Feb;68(2):588-96
pubmed: 1991357
Prog Biophys Mol Biol. 2011 Oct;107(1):60-73
pubmed: 21749896
J Cell Mol Med. 2012 Mar;16(3):468-82
pubmed: 22050625
Stem Cell Reports. 2016 Jul 12;7(1):29-42
pubmed: 27211213
J Clin Invest. 2012 Apr;122(4):1209-21
pubmed: 22426213
Arch Biochem Biophys. 2021 Jan 15;697:108711
pubmed: 33271148
Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1088-100
pubmed: 16565318
Sci Rep. 2013;3:2100
pubmed: 23812503

Auteurs

Mohamadamin Forouzandehmehr (M)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Jussi T Koivumäki (JT)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Jari Hyttinen (J)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Michelangelo Paci (M)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH